Universal-Beteiligungs- und Servicegesellschaft’s Avidity Biosciences RNAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,755
Closed -$992K 2135
2025
Q4
$992K Sell
13,755
-66,315
-83% -$4.28M ﹤0.01% 1493
2025
Q3
$3.49M Sell
80,070
-1,289
-2% -$52.1K 0.01% 1042
2025
Q2
$2.31M Sell
81,359
-103,788
-56% -$3.09M ﹤0.01% 1171
2025
Q1
$5.47M Buy
185,147
+22,784
+14% +$710K 0.01% 775
2024
Q4
$4.72M Buy
+162,363
New +$6.79M 0.01% 720

Other funds holding RNAM

Universal-Beteiligungs- und Servicegesellschaft's RNAM Position: Q1 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 13,755 shares — an estimated $992K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $5.47M in Q1 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Universal-Beteiligungs- und Servicegesellschaft reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Universal-Beteiligungs- und Servicegesellschaft sold 13,755 Avidity Biosciences shares in Q1 2026, an estimated $992K.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
  • Universal-Beteiligungs- und Servicegesellschaft's Avidity Biosciences position peaked at $5.47M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q1 2026, filed 11 May 2026.